Two separate complaints have been filed against the North Carolina Blue Cross and Blue Shield claiming discrimination against HIV patients. The suits, filed by the HIV+Hepatitis Policy Institute and the North Carolina AIDS Action Network, claim the insurance company places almost all HIV drugs, including generic PrEP, on the highest drug tier. This effectively causes those living with and vulnerable to HIV to pay the excessively high costs for their drugs.
HIV groups tell HHS Blue Cross Blue Shield NC plans discriminate
Blue Cross and Blue Shield of North Carolina is accused of discrimination for requiring HIV-infected individuals to pay high out of pocket costs for their medications, according to a complaint lodged with the Health and Human Services Department.
The Hill Morning Report
A new modeling study by the HIV+Hepatitis Policy Institute concludes that a $6 billion federal investment over a decade for drugs that prevent HIV infections, such as through the Pre-Exposure Prophylaxis (PrEP) program (UCLA Health), could reduce new HIV infections by 75 percent. The institute is lobbying Congress for additional HIV funding, arguing that taxpayers could eradicate the virus in the United States, achieving an estimated medical cost savings of $2.27 billion annually.
Blue Cross Blue Shield of N. Carolina accused of discrimination over high cost of HIV drugs
Two HIV organizations are accusing Blue Cross Blue Shield of North Carolina of discriminating against people who use drugs to treat or prevent the virus. The HIV+Hepatitis Policy Institute and the North Carolina AIDS Action Network filed discrimination complaints Thursday against the insurer for placing nearly all HIV medications on its highest-cost drug tiers.
Blue Cross and Blue Shield accused of placing most HIV drugs into highest tiers
HIV and hepatitis groups filed discrimination complaints against Blue Cross and Blue Shield of North Carolina, alleging that the health insurer placed nearly all HIV medications on the most expensive tiers. The complaints were filed by the HIV+Hepatitis Policy Institute and the North Carolina AIDS Action Network with the federal Office of Civil Rights at the Department of Health and Human Services as well as with the North Carolina Department of Insurance.